> top > docs > PMC:7242013 > annotations

PMC:7242013 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 13-18 Body_part denotes Liver http://purl.org/sig/ont/fma/fma7197
T2 67-72 Body_part denotes Liver http://purl.org/sig/ont/fma/fma7197
T3 283-288 Body_part denotes Liver http://purl.org/sig/ont/fma/fma7197
T4 302-309 Body_part denotes alanine http://purl.org/sig/ont/fma/fma82749
T5 380-385 Body_part denotes Liver http://purl.org/sig/ont/fma/fma7197
T6 477-482 Body_part denotes liver http://purl.org/sig/ont/fma/fma7197
T7 572-577 Body_part denotes Liver http://purl.org/sig/ont/fma/fma7197
T8 677-682 Body_part denotes liver http://purl.org/sig/ont/fma/fma7197
T9 724-729 Body_part denotes liver http://purl.org/sig/ont/fma/fma7197
T10 869-877 Body_part denotes tyrosine http://purl.org/sig/ont/fma/fma82768
T11 1111-1116 Body_part denotes liver http://purl.org/sig/ont/fma/fma7197
T12 1597-1602 Body_part denotes liver http://purl.org/sig/ont/fma/fma7197
T13 1856-1861 Body_part denotes Liver http://purl.org/sig/ont/fma/fma7197
T14 2064-2069 Body_part denotes liver http://purl.org/sig/ont/fma/fma7197
T15 2122-2127 Body_part denotes Liver http://purl.org/sig/ont/fma/fma7197
T16 2191-2196 Body_part denotes Liver http://purl.org/sig/ont/fma/fma7197
T17 2318-2323 Body_part denotes liver http://purl.org/sig/ont/fma/fma7197
T18 2554-2559 Body_part denotes Liver http://purl.org/sig/ont/fma/fma7197
T19 3422-3427 Body_part denotes liver http://purl.org/sig/ont/fma/fma7197
T20 3762-3767 Body_part denotes liver http://purl.org/sig/ont/fma/fma7197
T21 3997-4002 Body_part denotes liver http://purl.org/sig/ont/fma/fma7197
T22 4055-4060 Body_part denotes liver http://purl.org/sig/ont/fma/fma7197
T23 4568-4573 Body_part denotes liver http://purl.org/sig/ont/fma/fma7197
T24 4853-4858 Body_part denotes liver http://purl.org/sig/ont/fma/fma7197
T25 5216-5221 Body_part denotes liver http://purl.org/sig/ont/fma/fma7197
T26 7203-7208 Body_part denotes organ http://purl.org/sig/ont/fma/fma67498
T27 8169-8174 Body_part denotes Liver http://purl.org/sig/ont/fma/fma7197
T28 8289-8293 Body_part denotes face http://purl.org/sig/ont/fma/fma24728
T29 8297-8301 Body_part denotes face http://purl.org/sig/ont/fma/fma24728
T30 8685-8690 Body_part denotes liver http://purl.org/sig/ont/fma/fma7197
T31 9483-9488 Body_part denotes liver http://purl.org/sig/ont/fma/fma7197
T32 9939-9944 Body_part denotes Liver http://purl.org/sig/ont/fma/fma7197
T33 10100-10106 Body_part denotes Organs http://purl.org/sig/ont/fma/fma67498
T34 11289-11294 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T35 11470-11475 Body_part denotes liver http://purl.org/sig/ont/fma/fma7197
T36 11787-11792 Body_part denotes liver http://purl.org/sig/ont/fma/fma7197
T37 12870-12875 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T38 12876-12881 Body_part denotes liver http://purl.org/sig/ont/fma/fma7197
T39 12999-13004 Body_part denotes Liver http://purl.org/sig/ont/fma/fma7197
T40 13045-13055 Body_part denotes nucleotide http://purl.org/sig/ont/fma/fma82740
T41 13056-13059 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T42 13286-13291 Body_part denotes liver http://purl.org/sig/ont/fma/fma7197
T43 13421-13428 Body_part denotes alanine http://purl.org/sig/ont/fma/fma82749
T44 13844-13852 Body_part denotes tyrosine http://purl.org/sig/ont/fma/fma82768
T45 14241-14249 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T46 15586-15591 Body_part denotes liver http://purl.org/sig/ont/fma/fma7197
T47 15646-15651 Body_part denotes liver http://purl.org/sig/ont/fma/fma7197
T48 15872-15877 Body_part denotes liver http://purl.org/sig/ont/fma/fma7197

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1 100-108 Disease denotes COVID‐19 MESH:C000657245
3 283-297 Disease denotes Liver Diseases MESH:D008107
5 417-420 Disease denotes CHB
7 429-440 Disease denotes hepatitis B MESH:D006509
9 441-444 Disease denotes CHC MESH:D019698
11 445-464 Disease denotes chronic hepatitis C MESH:D019698
13 477-490 Disease denotes liver disease MESH:D008107
15 157-165 Disease denotes COVID‐19 MESH:C000657245
17 500-524 Disease denotes coronavirus disease 2019 MESH:C000657245
19 582-599 Disease denotes hepatitis B virus MESH:D006509
21 604-628 Disease denotes hepatocellular carcinoma MESH:D006528
23 633-650 Disease denotes hepatitis C virus MESH:D006526
25 718-737 Disease denotes fatty liver disease MESH:D005234
27 869-884 Gene denotes tyrosine kinase Gene:7294
29 895-898 Disease denotes ULD MESH:D020194
54 1097-1105 Species denotes patients Tax:9606
55 1258-1268 Species denotes SARS‐CoV‐2 Tax:2697049
56 1307-1314 Species denotes patient Tax:9606
57 1442-1450 Species denotes patients Tax:9606
58 1576-1583 Species denotes persons Tax:9606
59 1733-1740 Species denotes persons Tax:9606
60 1982-1990 Species denotes patients Tax:9606
61 2371-2381 Species denotes SARS‐CoV‐2 Tax:2697049
62 2407-2414 Species denotes persons Tax:9606
63 973-994 Disease denotes SARS‐coV‐2 infections MESH:C000657245
64 999-1023 Disease denotes coronavirus disease 2019 MESH:C000657245
65 1025-1033 Disease denotes COVID‐19 MESH:C000657245
66 1111-1124 Disease denotes liver disease MESH:D008107
67 1209-1229 Disease denotes SARS‐CoV‐2 infection MESH:C000657245
68 1234-1242 Disease denotes COVID‐19 MESH:C000657245
69 1513-1521 Disease denotes COVID‐19 MESH:C000657245
70 1534-1543 Disease denotes mortality MESH:D003643
71 1589-1610 Disease denotes chronic liver disease MESH:D058625
72 1629-1637 Disease denotes COVID‐19 MESH:C000657245
73 1721-1729 Disease denotes COVID‐19 MESH:C000657245
74 1937-1946 Disease denotes infection MESH:D007239
75 2011-2019 Disease denotes COVID‐19 MESH:C000657245
76 2122-2136 Disease denotes Liver Diseases MESH:D008107
77 2464-2472 Disease denotes COVID‐19 MESH:C000657245
160 4522-4526 Gene denotes IL‐6 Gene:3569
161 6545-6548 Gene denotes HCC Gene:619501
162 6364-6367 Gene denotes HCC Gene:619501
163 6272-6275 Gene denotes HCC Gene:619501
164 6101-6104 Gene denotes HCC Gene:619501
165 6087-6090 Gene denotes HCC Gene:619501
166 2686-2694 Species denotes patients Tax:9606
167 2738-2746 Species denotes patients Tax:9606
168 3194-3201 Species denotes patient Tax:9606
169 3364-3371 Species denotes patient Tax:9606
170 3735-3743 Species denotes patients Tax:9606
171 3814-3822 Species denotes patients Tax:9606
172 3843-3851 Species denotes patients Tax:9606
173 3910-3918 Species denotes patients Tax:9606
174 4435-4443 Species denotes patients Tax:9606
175 4592-4600 Species denotes patients Tax:9606
176 4742-4749 Species denotes persons Tax:9606
177 4798-4806 Species denotes patients Tax:9606
178 4979-4987 Species denotes patients Tax:9606
179 5161-5169 Species denotes patients Tax:9606
180 5342-5350 Species denotes patients Tax:9606
181 5573-5581 Species denotes patients Tax:9606
182 5634-5642 Species denotes patients Tax:9606
183 5717-5725 Species denotes patients Tax:9606
184 5801-5809 Species denotes patients Tax:9606
185 5862-5870 Species denotes patients Tax:9606
186 5945-5953 Species denotes patients Tax:9606
187 6019-6026 Species denotes patient Tax:9606
188 6073-6081 Species denotes patients Tax:9606
189 6350-6358 Species denotes patients Tax:9606
190 6599-6607 Species denotes patients Tax:9606
191 6729-6737 Species denotes patients Tax:9606
192 6825-6833 Species denotes patients Tax:9606
193 6904-6912 Species denotes patients Tax:9606
194 7043-7051 Species denotes patients Tax:9606
195 7183-7193 Species denotes SARS‐COV‐2 Tax:2697049
196 7300-7308 Species denotes patients Tax:9606
197 7355-7362 Species denotes patient Tax:9606
198 7493-7501 Species denotes patients Tax:9606
199 7593-7601 Species denotes patients Tax:9606
200 7758-7766 Species denotes patients Tax:9606
201 4712-4722 Chemical denotes remdesivir MESH:C000606551
202 2751-2759 Disease denotes COVID‐19 MESH:C000657245
203 2798-2806 Disease denotes COVID‐19 MESH:C000657245
204 3749-3757 Disease denotes COVID‐19 MESH:C000657245
205 3762-3775 Disease denotes liver disease MESH:D008107
206 3792-3800 Disease denotes COVID‐19 MESH:C000657245
207 3828-3837 Disease denotes cirrhosis MESH:D005355
208 3934-3948 Disease denotes encephalopathy MESH:D001927
209 4031-4039 Disease denotes COVID‐19 MESH:C000657245
210 4055-4068 Disease denotes liver disease MESH:D008107
211 4126-4144 Disease denotes hepatotoxicity Use
212 4351-4359 Disease denotes COVID‐19 MESH:C000657245
213 4419-4424 Disease denotes COVID MESH:C000657245
214 4448-4459 Disease denotes hepatitis B MESH:D006509
215 4631-4668 Disease denotes drug hepatotoxicity Decompensated CLD MESH:D019966
216 4686-4689 Disease denotes ULD MESH:D020194
217 4789-4797 Disease denotes COVID‐19 MESH:C000657245
218 4961-4966 Disease denotes COVID MESH:C000657245
219 4997-5005 Disease denotes COVID‐19 MESH:C000657245
220 5152-5160 Disease denotes COVID‐19 MESH:C000657245
221 5324-5329 Disease denotes COVID MESH:C000657245
222 5360-5368 Disease denotes COVID‐19 MESH:C000657245
223 5513-5551 Disease denotes hepatitis B; hepatitis C Continue HBV MESH:D006509
224 5587-5592 Disease denotes COVID MESH:C000657245
225 5651-5659 Disease denotes COVID‐19 MESH:C000657245
226 5731-5739 Disease denotes COVID‐19 MESH:C000657245
227 5815-5820 Disease denotes COVID MESH:C000657245
228 5879-5887 Disease denotes COVID‐19 MESH:C000657245
229 5959-5967 Disease denotes COVID‐19 MESH:C000657245
230 6328-6336 Disease denotes COVID‐19 MESH:C000657245
231 6373-6381 Disease denotes COVID‐19 MESH:C000657245
232 6503-6511 Disease denotes COVID‐19 MESH:C000657245
233 6641-6646 Disease denotes COVID MESH:C000657245
234 6876-6881 Disease denotes COVID MESH:C000657245
235 6927-6935 Disease denotes COVID‐19 MESH:C000657245
236 7062-7070 Disease denotes COVID‐19 MESH:C000657245
237 7110-7115 Disease denotes COVID MESH:C000657245
238 7377-7385 Disease denotes COVID‐19 MESH:C000657245
239 7512-7520 Disease denotes COVID‐19 MESH:C000657245
240 7651-7660 Disease denotes pneumonia MESH:D011014
241 7777-7785 Disease denotes COVID‐19 MESH:C000657245
244 2554-2567 Disease denotes Liver Disease MESH:D008107
245 2590-2598 Disease denotes COVID‐19 MESH:C000657245
249 8155-8163 Species denotes Patients Tax:9606
250 8169-8183 Disease denotes Liver Diseases MESH:D008107
251 8189-8209 Disease denotes SARS‐CoV‐2 Infection MESH:C000657245
267 8346-8353 Species denotes patient Tax:9606
268 8483-8490 Species denotes patient Tax:9606
269 8613-8623 Species denotes SARS‐CoV‐2 Tax:2697049
270 8641-8649 Species denotes patients Tax:9606
271 8728-8736 Species denotes patients Tax:9606
272 8831-8839 Species denotes patients Tax:9606
273 8915-8923 Species denotes patients Tax:9606
274 9068-9078 Species denotes SARS‐CoV‐2 Tax:2697049
275 9306-9316 Species denotes SARS‐CoV‐2 Tax:2697049
276 8576-8581 Disease denotes fever MESH:D005334
277 8591-8599 Disease denotes COVID‐19 MESH:C000657245
278 8665-8673 Disease denotes COVID‐19 MESH:C000657245
279 8742-8756 Disease denotes encephalopathy MESH:D001927
280 8816-8830 Disease denotes CoV‐2–infected MESH:C000657245
281 8992-9000 Disease denotes COVID‐19 MESH:C000657245
287 10015-10018 Gene denotes HCC Gene:619501
288 9581-9591 Species denotes SARS‐CoV‐2 Tax:2697049
289 9900-9908 Species denotes patients Tax:9606
290 9929-9952 Disease denotes End‐Stage Liver Disease MESH:D058625
291 9989-10013 Disease denotes hepatocellular carcinoma MESH:D006528
294 10060-10068 Disease denotes COVID‐19 MESH:C000657245
295 10121-10129 Disease denotes COVID‐19 MESH:C000657245
309 11087-11108 Gene denotes calcineurin inhibitor Gene:23523
310 10169-10177 Species denotes patients Tax:9606
311 10511-10519 Species denotes patients Tax:9606
312 10573-10583 Species denotes SARS‐CoV‐2 Tax:2697049
313 11013-11021 Species denotes patients Tax:9606
314 11054-11066 Chemical denotes azathioprine MESH:D001379
315 11068-11081 Chemical denotes mycophenolate MESH:D009173
316 10183-10191 Disease denotes COVID‐19 MESH:C000657245
317 10525-10533 Disease denotes COVID‐19 MESH:C000657245
318 10717-10725 Disease denotes COVID‐19 MESH:C000657245
319 10838-10846 Disease denotes COVID‐19 MESH:C000657245
320 11032-11040 Disease denotes COVID‐19 MESH:C000657245
321 11149-11160 Disease denotes lymphopenia MESH:D008231
324 11253-11260 Species denotes Patient Tax:9606
325 11266-11274 Disease denotes COVID‐19 MESH:C000657245
352 12557-12561 Gene denotes IL‐6 Gene:3569
353 11339-11347 Species denotes patients Tax:9606
354 11686-11694 Species denotes patients Tax:9606
355 11850-11858 Species denotes patients Tax:9606
356 11958-11966 Species denotes patients Tax:9606
357 12094-12102 Species denotes patients Tax:9606
358 12456-12464 Species denotes patients Tax:9606
359 12735-12743 Species denotes patients Tax:9606
360 12789-12800 Species denotes hepatitis C Tax:11103
361 11353-11361 Disease denotes COVID‐19 MESH:C000657245
362 11470-11482 Disease denotes liver injury MESH:D017093
363 11501-11522 Disease denotes SARS‐CoV‐2 infections MESH:C000657245
364 11573-11587 Disease denotes hepatotoxicity MESH:D056486
365 11734-11742 Disease denotes COVID‐19 MESH:C000657245
366 11781-11800 Disease denotes fatty liver disease MESH:D005234
367 11908-11916 Disease denotes COVID‐19 MESH:C000657245
368 12049-12057 Disease denotes COVID‐19 MESH:C000657245
369 12126-12174 Disease denotes chronic hepatitis B (CHB) or chronic hepatitis C MESH:D019698
370 12176-12179 Disease denotes CHC MESH:D019698
371 12214-12234 Disease denotes SARS‐CoV‐2 infection MESH:C000657245
372 12307-12310 Disease denotes CHB
373 12314-12317 Disease denotes CHC MESH:D019698
374 12325-12333 Disease denotes COVID‐19 MESH:C000657245
375 12442-12452 Disease denotes CHB or CHC MESH:D019698
376 12470-12478 Disease denotes COVID‐19 MESH:C000657245
377 12510-12521 Disease denotes hepatitis B MESH:D006509
381 12835-12842 Species denotes patient Tax:9606
382 12848-12856 Disease denotes COVID‐19 MESH:C000657245
383 12999-13013 Disease denotes Liver Diseases MESH:D008107
392 13421-13445 Gene denotes alanine aminotransferase Gene:2875
393 13193-13201 Species denotes patients Tax:9606
394 13304-13312 Species denotes patients Tax:9606
395 13374-13382 Species denotes Patients Tax:9606
396 13031-13041 Chemical denotes remdesivir MESH:C000606551
397 13362-13372 Chemical denotes remdesivir MESH:C000606551
398 13510-13520 Chemical denotes remdesivir MESH:C000606551
399 13227-13235 Disease denotes COVID‐19 MESH:C000657245
402 13572-13575 Gene denotes HCC Gene:619501
403 13558-13566 Species denotes Patients Tax:9606
418 14274-14277 Gene denotes HCC Gene:619501
419 14044-14047 Gene denotes HCC Gene:619501
420 13827-13830 Gene denotes HCC Gene:619501
421 13727-13730 Gene denotes HCC Gene:619501
422 13674-13677 Gene denotes HCC Gene:619501
423 13586-13596 Species denotes SARS‐CoV‐2 Tax:2697049
424 13644-13651 Species denotes patient Tax:9606
425 13783-13791 Species denotes patients Tax:9606
426 13924-13932 Species denotes patients Tax:9606
427 13844-13859 Gene denotes tyrosine kinase Gene:7294
428 13797-13805 Disease denotes COVID‐19 MESH:C000657245
429 13938-13946 Disease denotes COVID‐19 MESH:C000657245
430 14214-14222 Disease denotes COVID‐19 MESH:C000657245
431 14465-14473 Disease denotes COVID‐19 MESH:C000657245
435 14902-14912 Species denotes SARS‐CoV‐2 Tax:2697049
436 15092-15103 Species denotes participant Tax:9606
437 15057-15065 Disease denotes COVID‐19 MESH:C000657245
449 15633-15636 Gene denotes HCC Gene:619501
450 15373-15380 Species denotes patient Tax:9606
451 15434-15442 Species denotes patients Tax:9606
452 15559-15567 Species denotes patients Tax:9606
453 15619-15627 Species denotes patients Tax:9606
454 15663-15671 Species denotes patients Tax:9606
455 15728-15738 Species denotes SARS‐CoV‐2 Tax:2697049
456 15448-15468 Disease denotes SARS‐CoV‐2 infection MESH:C000657245
457 15573-15581 Disease denotes COVID‐19 MESH:C000657245
458 15586-15599 Disease denotes liver disease MESH:D008107
459 15962-15970 Disease denotes COVID‐19 MESH:C000657245

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 13-18 Body_part denotes Liver http://purl.obolibrary.org/obo/UBERON_0002107
T2 67-72 Body_part denotes Liver http://purl.obolibrary.org/obo/UBERON_0002107
T3 283-288 Body_part denotes Liver http://purl.obolibrary.org/obo/UBERON_0002107
T4 380-385 Body_part denotes Liver http://purl.obolibrary.org/obo/UBERON_0002107
T5 477-482 Body_part denotes liver http://purl.obolibrary.org/obo/UBERON_0002107
T6 572-577 Body_part denotes Liver http://purl.obolibrary.org/obo/UBERON_0002107
T7 677-682 Body_part denotes liver http://purl.obolibrary.org/obo/UBERON_0002107
T8 724-729 Body_part denotes liver http://purl.obolibrary.org/obo/UBERON_0002107
T9 1111-1116 Body_part denotes liver http://purl.obolibrary.org/obo/UBERON_0002107
T10 1597-1602 Body_part denotes liver http://purl.obolibrary.org/obo/UBERON_0002107
T11 1856-1861 Body_part denotes Liver http://purl.obolibrary.org/obo/UBERON_0002107
T12 2064-2069 Body_part denotes liver http://purl.obolibrary.org/obo/UBERON_0002107
T13 2122-2127 Body_part denotes Liver http://purl.obolibrary.org/obo/UBERON_0002107
T14 2191-2196 Body_part denotes Liver http://purl.obolibrary.org/obo/UBERON_0002107
T15 2318-2323 Body_part denotes liver http://purl.obolibrary.org/obo/UBERON_0002107
T16 2554-2559 Body_part denotes Liver http://purl.obolibrary.org/obo/UBERON_0002107
T17 3422-3427 Body_part denotes liver http://purl.obolibrary.org/obo/UBERON_0002107
T18 3762-3767 Body_part denotes liver http://purl.obolibrary.org/obo/UBERON_0002107
T19 3997-4002 Body_part denotes liver http://purl.obolibrary.org/obo/UBERON_0002107
T20 4055-4060 Body_part denotes liver http://purl.obolibrary.org/obo/UBERON_0002107
T21 4568-4573 Body_part denotes liver http://purl.obolibrary.org/obo/UBERON_0002107
T22 4853-4858 Body_part denotes liver http://purl.obolibrary.org/obo/UBERON_0002107
T23 5216-5221 Body_part denotes liver http://purl.obolibrary.org/obo/UBERON_0002107
T24 7203-7208 Body_part denotes organ http://purl.obolibrary.org/obo/UBERON_0000062
T25 8169-8174 Body_part denotes Liver http://purl.obolibrary.org/obo/UBERON_0002107
T26 8289-8293 Body_part denotes face http://purl.obolibrary.org/obo/UBERON_0001456
T27 8297-8301 Body_part denotes face http://purl.obolibrary.org/obo/UBERON_0001456
T28 8685-8690 Body_part denotes liver http://purl.obolibrary.org/obo/UBERON_0002107
T29 9483-9488 Body_part denotes liver http://purl.obolibrary.org/obo/UBERON_0002107
T30 9939-9944 Body_part denotes Liver http://purl.obolibrary.org/obo/UBERON_0002107
T31 10100-10106 Body_part denotes Organs http://purl.obolibrary.org/obo/UBERON_0000062
T32 11289-11294 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T33 11470-11475 Body_part denotes liver http://purl.obolibrary.org/obo/UBERON_0002107
T34 11787-11792 Body_part denotes liver http://purl.obolibrary.org/obo/UBERON_0002107
T35 12870-12875 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T36 12876-12881 Body_part denotes liver http://purl.obolibrary.org/obo/UBERON_0002107
T37 12999-13004 Body_part denotes Liver http://purl.obolibrary.org/obo/UBERON_0002107
T38 13286-13291 Body_part denotes liver http://purl.obolibrary.org/obo/UBERON_0002107
T39 15586-15591 Body_part denotes liver http://purl.obolibrary.org/obo/UBERON_0002107
T40 15646-15651 Body_part denotes liver http://purl.obolibrary.org/obo/UBERON_0002107
T41 15872-15877 Body_part denotes liver http://purl.obolibrary.org/obo/UBERON_0002107

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 100-108 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T2 157-165 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T3 421-440 Disease denotes chronic hepatitis B http://purl.obolibrary.org/obo/MONDO_0005344|http://purl.obolibrary.org/obo/MONDO_0005366
T5 421-438 Disease denotes chronic hepatitis http://purl.obolibrary.org/obo/MONDO_0002251
T6 445-464 Disease denotes chronic hepatitis C http://purl.obolibrary.org/obo/MONDO_0005231|http://purl.obolibrary.org/obo/MONDO_0005354
T8 445-462 Disease denotes chronic hepatitis http://purl.obolibrary.org/obo/MONDO_0002251
T9 465-468 Disease denotes CLD http://purl.obolibrary.org/obo/MONDO_0008964
T10 477-490 Disease denotes liver disease http://purl.obolibrary.org/obo/MONDO_0005154
T11 491-499 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T12 500-524 Disease denotes coronavirus disease 2019 http://purl.obolibrary.org/obo/MONDO_0100096
T13 582-593 Disease denotes hepatitis B http://purl.obolibrary.org/obo/MONDO_0005344
T14 582-591 Disease denotes hepatitis http://purl.obolibrary.org/obo/MONDO_0002251
T15 600-603 Disease denotes HCC http://purl.obolibrary.org/obo/MONDO_0007256
T16 604-628 Disease denotes hepatocellular carcinoma http://purl.obolibrary.org/obo/MONDO_0007256
T17 619-628 Disease denotes carcinoma http://purl.obolibrary.org/obo/MONDO_0004993
T18 633-644 Disease denotes hepatitis C http://purl.obolibrary.org/obo/MONDO_0005231
T19 633-642 Disease denotes hepatitis http://purl.obolibrary.org/obo/MONDO_0002251
T20 705-737 Disease denotes nonalcoholic fatty liver disease http://purl.obolibrary.org/obo/MONDO_0013209
T21 718-737 Disease denotes fatty liver disease http://purl.obolibrary.org/obo/MONDO_0004790
T22 806-810 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T23 817-864 Disease denotes Severe Acute Respiratory Syndrome Coronavirus 2 http://purl.obolibrary.org/obo/MONDO_0100096
T24 895-898 Disease denotes ULD http://purl.obolibrary.org/obo/MONDO_0009698
T25 973-977 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T26 984-994 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T27 999-1023 Disease denotes coronavirus disease 2019 http://purl.obolibrary.org/obo/MONDO_0100096
T28 1025-1033 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T29 1111-1124 Disease denotes liver disease http://purl.obolibrary.org/obo/MONDO_0005154
T30 1209-1213 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T31 1220-1229 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T32 1234-1242 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T33 1258-1262 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T34 1513-1521 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T35 1597-1610 Disease denotes liver disease http://purl.obolibrary.org/obo/MONDO_0005154
T36 1612-1615 Disease denotes CLD http://purl.obolibrary.org/obo/MONDO_0008964
T37 1629-1637 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T38 1721-1729 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T39 1746-1749 Disease denotes CLD http://purl.obolibrary.org/obo/MONDO_0008964
T40 1937-1946 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T41 1996-1999 Disease denotes CLD http://purl.obolibrary.org/obo/MONDO_0008964
T42 2011-2019 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T43 2371-2375 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T44 2420-2423 Disease denotes CLD http://purl.obolibrary.org/obo/MONDO_0008964
T45 2464-2472 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T46 2554-2567 Disease denotes Liver Disease http://purl.obolibrary.org/obo/MONDO_0005154
T47 2590-2598 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T48 2751-2759 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T49 2798-2806 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T50 3749-3757 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T51 3762-3775 Disease denotes liver disease http://purl.obolibrary.org/obo/MONDO_0005154
T52 3792-3800 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T53 3828-3837 Disease denotes cirrhosis http://purl.obolibrary.org/obo/MONDO_0005155
T54 3857-3860 Disease denotes CLD http://purl.obolibrary.org/obo/MONDO_0008964
T55 3934-3948 Disease denotes encephalopathy http://purl.obolibrary.org/obo/MONDO_0005560
T56 4031-4039 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T57 4055-4068 Disease denotes liver disease http://purl.obolibrary.org/obo/MONDO_0005154
T58 4102-4105 Disease denotes CLD http://purl.obolibrary.org/obo/MONDO_0008964
T59 4351-4359 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T60 4419-4427 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T61 4448-4459 Disease denotes hepatitis B http://purl.obolibrary.org/obo/MONDO_0005344
T62 4448-4457 Disease denotes hepatitis http://purl.obolibrary.org/obo/MONDO_0002251
T63 4606-4609 Disease denotes CLD http://purl.obolibrary.org/obo/MONDO_0008964
T64 4665-4668 Disease denotes CLD http://purl.obolibrary.org/obo/MONDO_0008964
T65 4686-4689 Disease denotes ULD http://purl.obolibrary.org/obo/MONDO_0009698
T66 4755-4758 Disease denotes CLD http://purl.obolibrary.org/obo/MONDO_0008964
T67 4789-4797 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T68 4961-4969 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T69 4993-4996 Disease denotes CLD http://purl.obolibrary.org/obo/MONDO_0008964
T70 4997-5005 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T71 5152-5160 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T72 5324-5332 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T73 5356-5359 Disease denotes CLD http://purl.obolibrary.org/obo/MONDO_0008964
T74 5360-5368 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T75 5513-5524 Disease denotes hepatitis B http://purl.obolibrary.org/obo/MONDO_0005344
T76 5513-5522 Disease denotes hepatitis http://purl.obolibrary.org/obo/MONDO_0002251
T77 5526-5537 Disease denotes hepatitis C http://purl.obolibrary.org/obo/MONDO_0005231
T78 5526-5535 Disease denotes hepatitis http://purl.obolibrary.org/obo/MONDO_0002251
T79 5587-5595 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T80 5651-5659 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T81 5731-5739 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T82 5815-5823 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T83 5879-5887 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T84 5959-5967 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T85 6037-6040 Disease denotes CLD http://purl.obolibrary.org/obo/MONDO_0008964
T86 6087-6090 Disease denotes HCC http://purl.obolibrary.org/obo/MONDO_0007256
T87 6101-6104 Disease denotes HCC http://purl.obolibrary.org/obo/MONDO_0007256
T88 6272-6275 Disease denotes HCC http://purl.obolibrary.org/obo/MONDO_0007256
T89 6328-6336 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T90 6364-6367 Disease denotes HCC http://purl.obolibrary.org/obo/MONDO_0007256
T91 6373-6381 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T92 6503-6511 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T93 6545-6548 Disease denotes HCC http://purl.obolibrary.org/obo/MONDO_0007256
T94 6641-6649 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T95 6709-6712 Disease denotes CMS http://purl.obolibrary.org/obo/MONDO_0018940
T96 6876-6884 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T97 6927-6935 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T98 7062-7070 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T99 7110-7118 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T100 7183-7187 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T101 7252-7261 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T102 7377-7385 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T103 7512-7520 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T104 7651-7660 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T105 7665-7668 Disease denotes flu http://purl.obolibrary.org/obo/MONDO_0005812
T106 7777-7785 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T107 7891-7899 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T108 8189-8193 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T109 8200-8209 Disease denotes Infection http://purl.obolibrary.org/obo/MONDO_0005550
T110 8591-8599 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T111 8613-8617 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T112 8665-8673 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T113 8742-8756 Disease denotes encephalopathy http://purl.obolibrary.org/obo/MONDO_0005560
T114 8811-8815 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T115 8992-9000 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T116 9068-9072 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T117 9306-9310 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T118 9581-9585 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T119 9939-9952 Disease denotes Liver Disease http://purl.obolibrary.org/obo/MONDO_0005154
T120 9989-10013 Disease denotes hepatocellular carcinoma http://purl.obolibrary.org/obo/MONDO_0007256
T121 10004-10013 Disease denotes carcinoma http://purl.obolibrary.org/obo/MONDO_0004993
T122 10015-10018 Disease denotes HCC http://purl.obolibrary.org/obo/MONDO_0007256
T123 10060-10068 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T124 10121-10129 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T125 10183-10191 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T126 10525-10533 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T127 10573-10577 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T128 10717-10725 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T129 10838-10846 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T130 11032-11040 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T131 11149-11160 Disease denotes lymphopenia http://purl.obolibrary.org/obo/MONDO_0003783
T132 11266-11274 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T133 11353-11361 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T134 11476-11482 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T135 11501-11505 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T136 11512-11522 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T137 11552-11555 Disease denotes CLD http://purl.obolibrary.org/obo/MONDO_0008964
T138 11700-11703 Disease denotes CLD http://purl.obolibrary.org/obo/MONDO_0008964
T139 11734-11742 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T140 11768-11800 Disease denotes nonalcoholic fatty liver disease http://purl.obolibrary.org/obo/MONDO_0013209
T141 11781-11800 Disease denotes fatty liver disease http://purl.obolibrary.org/obo/MONDO_0004790
T142 11864-11867 Disease denotes CLD http://purl.obolibrary.org/obo/MONDO_0008964
T143 11908-11916 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T144 12049-12057 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T145 12115-12118 Disease denotes CLD http://purl.obolibrary.org/obo/MONDO_0008964
T146 12126-12145 Disease denotes chronic hepatitis B http://purl.obolibrary.org/obo/MONDO_0005344|http://purl.obolibrary.org/obo/MONDO_0005366
T148 12126-12143 Disease denotes chronic hepatitis http://purl.obolibrary.org/obo/MONDO_0002251
T149 12155-12174 Disease denotes chronic hepatitis C http://purl.obolibrary.org/obo/MONDO_0005231|http://purl.obolibrary.org/obo/MONDO_0005354
T151 12155-12172 Disease denotes chronic hepatitis http://purl.obolibrary.org/obo/MONDO_0002251
T152 12214-12218 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T153 12225-12234 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T154 12325-12333 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T155 12470-12478 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T156 12510-12521 Disease denotes hepatitis B http://purl.obolibrary.org/obo/MONDO_0005344
T157 12510-12519 Disease denotes hepatitis http://purl.obolibrary.org/obo/MONDO_0002251
T158 12622-12633 Disease denotes hepatitis C http://purl.obolibrary.org/obo/MONDO_0005231
T159 12622-12631 Disease denotes hepatitis http://purl.obolibrary.org/obo/MONDO_0002251
T160 12774-12785 Disease denotes hepatitis B http://purl.obolibrary.org/obo/MONDO_0005344
T161 12774-12783 Disease denotes hepatitis http://purl.obolibrary.org/obo/MONDO_0002251
T162 12789-12800 Disease denotes hepatitis C http://purl.obolibrary.org/obo/MONDO_0005231
T163 12789-12798 Disease denotes hepatitis http://purl.obolibrary.org/obo/MONDO_0002251
T164 12848-12856 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T165 13227-13235 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T166 13336-13339 Disease denotes CLD http://purl.obolibrary.org/obo/MONDO_0008964
T167 13402-13405 Disease denotes CLD http://purl.obolibrary.org/obo/MONDO_0008964
T168 13572-13575 Disease denotes HCC http://purl.obolibrary.org/obo/MONDO_0007256
T169 13586-13590 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T170 13674-13677 Disease denotes HCC http://purl.obolibrary.org/obo/MONDO_0007256
T171 13727-13730 Disease denotes HCC http://purl.obolibrary.org/obo/MONDO_0007256
T172 13797-13805 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T173 13827-13830 Disease denotes HCC http://purl.obolibrary.org/obo/MONDO_0007256
T174 13938-13946 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T175 14044-14047 Disease denotes HCC http://purl.obolibrary.org/obo/MONDO_0007256
T176 14214-14222 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T177 14274-14277 Disease denotes HCC http://purl.obolibrary.org/obo/MONDO_0007256
T178 14465-14473 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T179 14902-14906 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T180 15057-15065 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T181 15448-15452 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T182 15459-15468 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T183 15573-15581 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T184 15586-15599 Disease denotes liver disease http://purl.obolibrary.org/obo/MONDO_0005154
T185 15633-15636 Disease denotes HCC http://purl.obolibrary.org/obo/MONDO_0007256
T186 15728-15732 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T187 15947-15950 Disease denotes CLD http://purl.obolibrary.org/obo/MONDO_0008964
T188 15962-15970 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 13-18 http://purl.obolibrary.org/obo/UBERON_0002107 denotes Liver
T2 13-18 http://www.ebi.ac.uk/efo/EFO_0000887 denotes Liver
T3 67-72 http://purl.obolibrary.org/obo/UBERON_0002107 denotes Liver
T4 67-72 http://www.ebi.ac.uk/efo/EFO_0000887 denotes Liver
T5 283-288 http://purl.obolibrary.org/obo/UBERON_0002107 denotes Liver
T6 283-288 http://www.ebi.ac.uk/efo/EFO_0000887 denotes Liver
T7 380-385 http://purl.obolibrary.org/obo/UBERON_0002107 denotes Liver
T8 380-385 http://www.ebi.ac.uk/efo/EFO_0000887 denotes Liver
T9 439-440 http://purl.obolibrary.org/obo/CLO_0001021 denotes B
T10 477-482 http://purl.obolibrary.org/obo/UBERON_0002107 denotes liver
T11 477-482 http://www.ebi.ac.uk/efo/EFO_0000887 denotes liver
T12 572-577 http://purl.obolibrary.org/obo/UBERON_0002107 denotes Liver
T13 572-577 http://www.ebi.ac.uk/efo/EFO_0000887 denotes Liver
T14 592-593 http://purl.obolibrary.org/obo/CLO_0001021 denotes B
T15 594-599 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T16 645-650 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T17 674-676 http://purl.obolibrary.org/obo/CLO_0007408 denotes LT
T18 677-682 http://purl.obolibrary.org/obo/UBERON_0002107 denotes liver
T19 677-682 http://www.ebi.ac.uk/efo/EFO_0000887 denotes liver
T20 724-729 http://purl.obolibrary.org/obo/UBERON_0002107 denotes liver
T21 724-729 http://www.ebi.ac.uk/efo/EFO_0000887 denotes liver
T22 1111-1116 http://purl.obolibrary.org/obo/UBERON_0002107 denotes liver
T23 1111-1116 http://www.ebi.ac.uk/efo/EFO_0000887 denotes liver
T24 1597-1602 http://purl.obolibrary.org/obo/UBERON_0002107 denotes liver
T25 1597-1602 http://www.ebi.ac.uk/efo/EFO_0000887 denotes liver
T26 1856-1861 http://purl.obolibrary.org/obo/UBERON_0002107 denotes Liver
T27 1856-1861 http://www.ebi.ac.uk/efo/EFO_0000887 denotes Liver
T28 2064-2069 http://purl.obolibrary.org/obo/UBERON_0002107 denotes liver
T29 2064-2069 http://www.ebi.ac.uk/efo/EFO_0000887 denotes liver
T30 2122-2127 http://purl.obolibrary.org/obo/UBERON_0002107 denotes Liver
T31 2122-2127 http://www.ebi.ac.uk/efo/EFO_0000887 denotes Liver
T32 2191-2196 http://purl.obolibrary.org/obo/UBERON_0002107 denotes Liver
T33 2191-2196 http://www.ebi.ac.uk/efo/EFO_0000887 denotes Liver
T34 2242-2252 http://purl.obolibrary.org/obo/BFO_0000030 denotes objectives
T35 2318-2323 http://purl.obolibrary.org/obo/UBERON_0002107 denotes liver
T36 2318-2323 http://www.ebi.ac.uk/efo/EFO_0000887 denotes liver
T37 2554-2559 http://purl.obolibrary.org/obo/UBERON_0002107 denotes Liver
T38 2554-2559 http://www.ebi.ac.uk/efo/EFO_0000887 denotes Liver
T39 3124-3132 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T40 3422-3427 http://purl.obolibrary.org/obo/UBERON_0002107 denotes liver
T41 3422-3427 http://www.ebi.ac.uk/efo/EFO_0000887 denotes liver
T42 3762-3767 http://purl.obolibrary.org/obo/UBERON_0002107 denotes liver
T43 3762-3767 http://www.ebi.ac.uk/efo/EFO_0000887 denotes liver
T44 3801-3808 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T45 3997-4002 http://purl.obolibrary.org/obo/UBERON_0002107 denotes liver
T46 3997-4002 http://www.ebi.ac.uk/efo/EFO_0000887 denotes liver
T47 4055-4060 http://purl.obolibrary.org/obo/UBERON_0002107 denotes liver
T48 4055-4060 http://www.ebi.ac.uk/efo/EFO_0000887 denotes liver
T49 4388-4389 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T50 4458-4459 http://purl.obolibrary.org/obo/CLO_0001021 denotes B
T51 4568-4573 http://purl.obolibrary.org/obo/UBERON_0002107 denotes liver
T52 4568-4573 http://www.ebi.ac.uk/efo/EFO_0000887 denotes liver
T53 4583-4588 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tests
T54 4780-4784 http://purl.obolibrary.org/obo/UBERON_0000473 denotes Test
T55 4853-4858 http://purl.obolibrary.org/obo/UBERON_0002107 denotes liver
T56 4853-4858 http://www.ebi.ac.uk/efo/EFO_0000887 denotes liver
T57 5143-5147 http://purl.obolibrary.org/obo/UBERON_0000473 denotes Test
T58 5216-5221 http://purl.obolibrary.org/obo/UBERON_0002107 denotes liver
T59 5216-5221 http://www.ebi.ac.uk/efo/EFO_0000887 denotes liver
T60 5523-5524 http://purl.obolibrary.org/obo/CLO_0001021 denotes B
T61 7080-7084 http://purl.obolibrary.org/obo/UBERON_0000473 denotes Test
T62 7203-7208 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organ
T63 8169-8174 http://purl.obolibrary.org/obo/UBERON_0002107 denotes Liver
T64 8169-8174 http://www.ebi.ac.uk/efo/EFO_0000887 denotes Liver
T65 8289-8293 http://purl.obolibrary.org/obo/UBERON_0001456 denotes face
T66 8297-8301 http://purl.obolibrary.org/obo/UBERON_0001456 denotes face
T67 8624-8631 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T68 8674-8681 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T69 8685-8690 http://purl.obolibrary.org/obo/UBERON_0002107 denotes liver
T70 8685-8690 http://www.ebi.ac.uk/efo/EFO_0000887 denotes liver
T71 8929-8930 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T72 9043-9049 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T73 9079-9086 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T74 9317-9324 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T75 9483-9488 http://purl.obolibrary.org/obo/UBERON_0002107 denotes liver
T76 9483-9488 http://www.ebi.ac.uk/efo/EFO_0000887 denotes liver
T77 9506-9508 http://purl.obolibrary.org/obo/CLO_0007408 denotes LT
T78 9739-9741 http://purl.obolibrary.org/obo/CLO_0007408 denotes LT
T79 9894-9896 http://purl.obolibrary.org/obo/CLO_0007408 denotes LT
T80 9939-9944 http://purl.obolibrary.org/obo/UBERON_0002107 denotes Liver
T81 9939-9944 http://www.ebi.ac.uk/efo/EFO_0000887 denotes Liver
T82 10041-10043 http://purl.obolibrary.org/obo/CLO_0007408 denotes LT
T83 10100-10106 http://purl.obolibrary.org/obo/UBERON_0003103 denotes Organs
T84 10163-10165 http://purl.obolibrary.org/obo/CLO_0007408 denotes LT
T85 10193-10195 http://purl.obolibrary.org/obo/CLO_0007408 denotes LT
T86 10265-10270 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tests
T87 10329-10331 http://purl.obolibrary.org/obo/CLO_0007408 denotes LT
T88 10487-10489 http://purl.obolibrary.org/obo/CLO_0007408 denotes LT
T89 10813-10814 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T90 11010-11012 http://purl.obolibrary.org/obo/CLO_0007408 denotes LT
T91 11215-11216 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T92 11251-11252 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T93 11367-11368 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T94 11470-11475 http://purl.obolibrary.org/obo/UBERON_0002107 denotes liver
T95 11470-11475 http://www.ebi.ac.uk/efo/EFO_0000887 denotes liver
T96 11660-11661 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T97 11709-11710 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T98 11787-11792 http://purl.obolibrary.org/obo/UBERON_0002107 denotes liver
T99 11787-11792 http://www.ebi.ac.uk/efo/EFO_0000887 denotes liver
T100 12144-12145 http://purl.obolibrary.org/obo/CLO_0001021 denotes B
T101 12520-12521 http://purl.obolibrary.org/obo/CLO_0001021 denotes B
T102 12692-12693 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T103 12784-12785 http://purl.obolibrary.org/obo/CLO_0001021 denotes B
T104 12876-12881 http://purl.obolibrary.org/obo/UBERON_0002107 denotes liver
T105 12876-12881 http://www.ebi.ac.uk/efo/EFO_0000887 denotes liver
T106 12999-13004 http://purl.obolibrary.org/obo/UBERON_0002107 denotes Liver
T107 12999-13004 http://www.ebi.ac.uk/efo/EFO_0000887 denotes Liver
T108 13043-13044 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T109 13286-13291 http://purl.obolibrary.org/obo/UBERON_0002107 denotes liver
T110 13286-13291 http://www.ebi.ac.uk/efo/EFO_0000887 denotes liver
T111 13663-13664 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T112 14239-14240 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T113 14493-14494 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T114 14629-14637 http://purl.obolibrary.org/obo/UBERON_0001637 denotes arterial
T115 14629-14637 http://www.ebi.ac.uk/efo/EFO_0000814 denotes arterial
T116 15586-15591 http://purl.obolibrary.org/obo/UBERON_0002107 denotes liver
T117 15586-15591 http://www.ebi.ac.uk/efo/EFO_0000887 denotes liver
T118 15646-15651 http://purl.obolibrary.org/obo/UBERON_0002107 denotes liver
T119 15646-15651 http://www.ebi.ac.uk/efo/EFO_0000887 denotes liver
T120 15739-15746 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T121 15872-15877 http://purl.obolibrary.org/obo/UBERON_0002107 denotes liver
T122 15872-15877 http://www.ebi.ac.uk/efo/EFO_0000887 denotes liver

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 175-178 Chemical denotes Lau http://purl.obolibrary.org/obo/CHEBI_32359
T2 302-309 Chemical denotes alanine http://purl.obolibrary.org/obo/CHEBI_16449
T3 386-389 Chemical denotes AST http://purl.obolibrary.org/obo/CHEBI_76649
T4 390-399 Chemical denotes aspartate http://purl.obolibrary.org/obo/CHEBI_132943|http://purl.obolibrary.org/obo/CHEBI_29995|http://purl.obolibrary.org/obo/CHEBI_72314
T7 674-676 Chemical denotes LT http://purl.obolibrary.org/obo/CHEBI_73589
T8 869-894 Chemical denotes tyrosine kinase inhibitor http://purl.obolibrary.org/obo/CHEBI_38637
T9 869-877 Chemical denotes tyrosine http://purl.obolibrary.org/obo/CHEBI_18186
T10 885-894 Chemical denotes inhibitor http://purl.obolibrary.org/obo/CHEBI_35222
T11 1661-1665 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T12 1666-1670 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T13 4113-4117 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T14 4208-4231 Chemical denotes anti‐inflammatory drugs http://purl.obolibrary.org/obo/CHEBI_35472
T15 4226-4231 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T16 4306-4310 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T17 4468-4475 Chemical denotes antigen http://purl.obolibrary.org/obo/CHEBI_59132
T18 4522-4524 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T20 4631-4635 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T21 4712-4722 Chemical denotes remdesivir http://purl.obolibrary.org/obo/CHEBI_145994
T22 5119-5142 Chemical denotes anti‐inflammatory drugs http://purl.obolibrary.org/obo/CHEBI_35472
T23 5137-5142 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T24 5482-5505 Chemical denotes anti‐inflammatory drugs http://purl.obolibrary.org/obo/CHEBI_35472
T25 5500-5505 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T26 5506-5512 Chemical denotes Manage http://purl.obolibrary.org/obo/CHEBI_81767
T27 6066-6072 Chemical denotes Manage http://purl.obolibrary.org/obo/CHEBI_81767
T28 6559-6565 Chemical denotes Manage http://purl.obolibrary.org/obo/CHEBI_81767
T29 9506-9508 Chemical denotes LT http://purl.obolibrary.org/obo/CHEBI_73589
T30 9739-9741 Chemical denotes LT http://purl.obolibrary.org/obo/CHEBI_73589
T31 9894-9896 Chemical denotes LT http://purl.obolibrary.org/obo/CHEBI_73589
T32 10041-10043 Chemical denotes LT http://purl.obolibrary.org/obo/CHEBI_73589
T33 10163-10165 Chemical denotes LT http://purl.obolibrary.org/obo/CHEBI_73589
T34 10193-10195 Chemical denotes LT http://purl.obolibrary.org/obo/CHEBI_73589
T35 10329-10331 Chemical denotes LT http://purl.obolibrary.org/obo/CHEBI_73589
T36 10487-10489 Chemical denotes LT http://purl.obolibrary.org/obo/CHEBI_73589
T37 10584-10596 Chemical denotes nucleic acid http://purl.obolibrary.org/obo/CHEBI_33696
T38 10592-10596 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T39 11010-11012 Chemical denotes LT http://purl.obolibrary.org/obo/CHEBI_73589
T40 11054-11066 Chemical denotes azathioprine http://purl.obolibrary.org/obo/CHEBI_2948
T41 11068-11081 Chemical denotes mycophenolate http://purl.obolibrary.org/obo/CHEBI_62932
T42 11087-11108 Chemical denotes calcineurin inhibitor http://purl.obolibrary.org/obo/CHEBI_37153
T43 11087-11098 Chemical denotes calcineurin http://purl.obolibrary.org/obo/CHEBI_53439
T44 11099-11108 Chemical denotes inhibitor http://purl.obolibrary.org/obo/CHEBI_35222
T45 11560-11564 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T46 11917-11921 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T47 12557-12559 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T49 13031-13041 Chemical denotes remdesivir http://purl.obolibrary.org/obo/CHEBI_145994
T50 13045-13055 Chemical denotes nucleotide http://purl.obolibrary.org/obo/CHEBI_36976
T51 13056-13080 Chemical denotes RNA polymerase inhibitor http://purl.obolibrary.org/obo/CHEBI_37416
T52 13071-13080 Chemical denotes inhibitor http://purl.obolibrary.org/obo/CHEBI_35222
T53 13362-13372 Chemical denotes remdesivir http://purl.obolibrary.org/obo/CHEBI_145994
T54 13421-13428 Chemical denotes alanine http://purl.obolibrary.org/obo/CHEBI_16449
T55 13510-13520 Chemical denotes remdesivir http://purl.obolibrary.org/obo/CHEBI_145994
T56 13844-13870 Chemical denotes tyrosine kinase inhibitors http://purl.obolibrary.org/obo/CHEBI_38637
T57 13844-13852 Chemical denotes tyrosine http://purl.obolibrary.org/obo/CHEBI_18186
T58 13860-13870 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T59 13892-13902 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T60 14190-14200 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T61 14404-14413 Chemical denotes inhibitor http://purl.obolibrary.org/obo/CHEBI_35222

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T1 0-9 http://purl.obolibrary.org/obo/GO_0009058 denotes Synthesis
T2 878-894 http://purl.obolibrary.org/obo/GO_0033673 denotes kinase inhibitor
T3 11087-11098 http://purl.obolibrary.org/obo/GO_0004723 denotes calcineurin
T4 11087-11098 http://purl.obolibrary.org/obo/GO_0004722 denotes calcineurin
T5 13853-13870 http://purl.obolibrary.org/obo/GO_0033673 denotes kinase inhibitors

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-117 Sentence denotes Synthesis of Liver Associations Recommendations for Hepatology and Liver Transplant Care During the COVID‐19 Pandemic
T2 118-174 Sentence denotes Hepatology and Patient Care During the COVID‐19 Pandemic
T3 175-187 Sentence denotes Lau and Ward
T4 189-224 Sentence denotes Watch the interview with the author
T5 225-238 Sentence denotes Abbreviations
T6 239-297 Sentence denotes AASLD American Association for the Study of Liver Diseases
T7 298-326 Sentence denotes ALT alanine aminotransferase
T8 327-385 Sentence denotes APASL Asian Pacific Association for the Study of the Liver
T9 386-416 Sentence denotes AST aspartate aminotransferase
T10 417-440 Sentence denotes CHB chronic hepatitis B
T11 441-464 Sentence denotes CHC chronic hepatitis C
T12 465-490 Sentence denotes CLD chronic liver disease
T13 491-524 Sentence denotes COVID‐19 coronavirus disease 2019
T14 525-577 Sentence denotes EASL European Association for the Study of the Liver
T15 578-599 Sentence denotes HBV hepatitis B virus
T16 600-628 Sentence denotes HCC hepatocellular carcinoma
T17 629-650 Sentence denotes HCV hepatitis C virus
T18 651-673 Sentence denotes HCW health care worker
T19 674-698 Sentence denotes LT liver transplantation
T20 699-737 Sentence denotes NAFLD nonalcoholic fatty liver disease
T21 738-771 Sentence denotes NIH National Institutes of Health
T22 772-805 Sentence denotes PPE personal protective equipment
T23 806-864 Sentence denotes SARS‐CoV‐2 Severe Acute Respiratory Syndrome Coronavirus 2
T24 865-894 Sentence denotes TKI tyrosine kinase inhibitor
T25 895-920 Sentence denotes ULD upper limit of normal
T26 921-1243 Sentence denotes To navigate through the stormy unchartered ocean of SARS‐coV‐2 infections and coronavirus disease 2019 (COVID‐19), all practicing hepatologists and other clinicians caring for patients with liver disease need guidance based on the best documented and rapidly evolving knowledge regarding SARS‐CoV‐2 infection and COVID‐19.
T27 1244-1473 Sentence denotes Prevention of SARS‐CoV‐2 transmission requires the redesign of patient workflow and other measures ensuring delivery of elective and emergency hepatology services without compromising the safety of patients and medical personnel.
T28 1474-1750 Sentence denotes 1 , 2 Moreover, prevention of severe COVID‐19 and related mortality requires updating management of persons with chronic liver disease (CLD) to diagnose COVID‐19 and being vigilant for drug‐drug interactions and other potential complications of COVID‐19 in persons with CLD.
T29 1751-2029 Sentence denotes 3 To respond to an urgent need for such information, the Asian Pacific Association for the Study of the Liver (APASL) recently published recommendations of an expert committee to guide infection control and clinical management of patients with CLD during the COVID‐19 pandemic.
T30 2030-2253 Sentence denotes 4 Previously, two other regional liver associations, American Association for the Study of Liver Diseases (AASLD) and European Association for the Study of the Liver (EASL), convened expert panels with the same objectives.
T31 2254-2492 Sentence denotes 5 , 6 This review summarizes the recommendations of the three liver associations for clinical practices to prevent SARS‐CoV‐2 transmission and protect persons with CLD from health risks posed by the emerging COVID‐19 pandemic (Table 1).
T32 2493-2607 Sentence denotes Table 1 Selected AASLD, APASL, and EASL Recommendations for Liver Disease Management During the COVID‐19 Pandemic
T33 2608-2643 Sentence denotes Recommendations AASLD APASL EASL
T34 2644-2718 Sentence denotes Limit nosocomial transmission Prioritize patients to limit in‐person care
T35 2719-2865 Sentence denotes On arrival, screen patients for COVID‐19 symptoms, exposures; if suggestive of COVID‐19, refer care per clinic’s protocol for symptomatic patients
T36 2866-2912 Sentence denotes Use telemedicine alternatives for routine care
T37 2913-2961 Sentence denotes Reduce routine laboratory and imaging monitoring
T38 2962-2994 Sentence denotes Prescribe 90 days of medications
T39 2995-3059 Sentence denotes Cancel all elective/nonurgent endoscopic procedures and biopsies
T40 3060-3102 Sentence denotes Limit in‐clinic evaluations for transplant
T41 3103-3161 Sentence denotes Limit clinical trial activity to essential clinical trials
T42 3162-3208 Sentence denotes Limit HCWs providing care or on patient rounds
T43 3209-3292 Sentence denotes HCWs follow recommendations for PPE Use telemedicine alternatives for routine care
T44 3293-3336 Sentence denotes Minimize number of HCWs caring for patients
T45 3337-3378 Sentence denotes Minimize number of HCWs on patient rounds
T46 3379-3436 Sentence denotes Cancel elective, nonurgent endoscopies and liver biopsies
T47 3437-3510 Sentence denotes HCWs follow recommendations for PPE Limit in‐person care to urgent cases
T48 3511-3553 Sentence denotes Remodel clinic space for social distancing
T49 3554-3615 Sentence denotes Use telemedicine for routine care; postpone specialist visits
T50 3616-3676 Sentence denotes Reduce frequency of laboratory monitoring and obtain locally
T51 3677-3712 Sentence denotes HCWs follow recommendations for PPE
T52 3713-3978 Sentence denotes Evaluate and care for patients with COVID‐19 for liver disease Prioritize for COVID‐19 testing: (1) patients with cirrhosis, (2) patients with CLD receiving immunosuppressive medications, and (3) patients with new‐onset encephalopathy or other acute decompensation
T53 3979-4017 Sentence denotes Regularly monitor liver biochemistries
T54 4018-4140 Sentence denotes Consider non‐COVID‐19 etiologies for liver disease: (1) exacerbation of preexisting CLD or (2) drug‐induced hepatotoxicity
T55 4141-4190 Sentence denotes Use acetaminophen 2 g/day as preferred medication
T56 4191-4241 Sentence denotes Use nonsteroidal anti‐inflammatory drugs as needed
T57 4242-4369 Sentence denotes Consult the University of Liverpool document to assess possible drug interactions Follow WHO guidelines for COVID‐19 diagnosis
T58 4370-4427 Sentence denotes Consider NAFLD as a prognostic factor for severe COVID‐19
T59 4428-4475 Sentence denotes Screen patients for hepatitis B surface antigen
T60 4476-4559 Sentence denotes Consider HBV prophylaxis prior to use of anti‐IL‐6, other immunosuppressive therapy
T61 4560-4609 Sentence denotes Monitor liver function tests of patients with CLD
T62 4610-4650 Sentence denotes Be alert to possible drug hepatotoxicity
T63 4651-4730 Sentence denotes Decompensated CLD and ALT >5 times ULD contraindications for remdesivir therapy
T64 4731-4890 Sentence denotes Prioritize persons with CLD for clinical trials Test for COVID‐19 patients with acute decompensation or acute‐on‐chronic liver and per institution’s practices
T65 4891-4969 Sentence denotes Persons with NAFLD likely to have comorbidity risk factors for severe COVID‐19
T66 4970-5044 Sentence denotes Consider patients with CLD/COVID‐19 for early admission and clinical trial
T67 5045-5092 Sentence denotes Use acetaminophen (2–3 g/day is generally safe)
T68 5093-5142 Sentence denotes Limit use of nonsteroidal anti‐inflammatory drugs
T69 5143-5253 Sentence denotes Test for COVID‐19 patients with acute decompensation or acute‐on‐chronic liver and per institution’s practices
T70 5254-5332 Sentence denotes Persons with NAFLD likely to have comorbidity risk factors for severe COVID‐19
T71 5333-5407 Sentence denotes Consider patients with CLD/COVID‐19 for early admission and clinical trial
T72 5408-5455 Sentence denotes Use acetaminophen (2–3 g/day is generally safe)
T73 5456-5505 Sentence denotes Limit use of nonsteroidal anti‐inflammatory drugs
T74 5506-5595 Sentence denotes Manage hepatitis B; hepatitis C Continue HBV and HCV treatment of patients with COVID‐19
T75 5596-5683 Sentence denotes Proceed with HBV and HCV treatment in patients without COVID‐19 as clinically warranted
T76 5684-5823 Sentence denotes Do not consider HBV treatment in patients with COVID‐19 unless flare is suspected Continue HBV and HCV treatment of patients with COVID‐19
T77 5824-5911 Sentence denotes Proceed with HBV and HCV treatment in patients without COVID‐19 as clinically warranted
T78 5912-5993 Sentence denotes Do not consider HBV treatment in patients with COVID‐19 unless flare is suspected
T79 5994-6065 Sentence denotes Document discussion with patient regarding CLD diagnosis and management
T80 6066-6178 Sentence denotes Manage patients with HCC Continue HCC surveillance schedule for high‐risk subjects; 2‐month delay is acceptable
T81 6179-6258 Sentence denotes Document discussion of risks and benefits of delaying surveillance with patient
T82 6259-6345 Sentence denotes Proceed with HCC treatments as appropriate Continue therapy for non‐COVID‐19 patients
T83 6346-6487 Sentence denotes For patients with HCC with COVID‐19, postpone elective transplant and resection surgery, withhold immunotherapy Maintain care per guidelines
T84 6488-6524 Sentence denotes Admit early if COVID‐19 is diagnosed
T85 6525-6558 Sentence denotes Consider postponing HCC therapies
T86 6559-6649 Sentence denotes Manage pretransplant and posttransplant patients Screen donors and recipient for COVID‐19
T87 6650-6721 Sentence denotes Do not postpone transplants (an essential medical service, CMS Tier 3b)
T88 6722-6791 Sentence denotes Notify patients of possible extended waiting times on transplant list
T89 6792-6884 Sentence denotes Have low threshold for admitting patients on transplant waiting list diagnosed with COVID‐19
T90 6885-6999 Sentence denotes For posttransplant patients with moderate COVID‐19, consider reduction of immunosuppression therapy as appropriate
T91 7000-7118 Sentence denotes Do not reduce immunosuppressive therapy in patients with mild COVID‐19 disease Test donors and recipient for COVID‐19
T92 7119-7173 Sentence denotes Limit transplant listing to emergency and urgent cases
T93 7174-7261 Sentence denotes Look for SARS‐COV‐2 prior to organ procurement; defer donors with evidence of infection
T94 7262-7335 Sentence denotes Consider specific COVD‐19 consent for patients on transplant waiting list
T95 7336-7449 Sentence denotes For posttransplant patient with moderate COVID‐19, consider reduction of immunosuppression therapy as appropriate
T96 7450-7558 Sentence denotes Do not reduce immunosuppressive therapy in patients with mild COVID‐19 disease Maintain care per guidelines
T97 7559-7632 Sentence denotes Limit transplantation listings to patients with poor short‐term prognosis
T98 7633-7668 Sentence denotes Vaccinate against pneumonia and flu
T99 7669-7714 Sentence denotes Avoid reductions in immunosuppressive therapy
T100 7715-7785 Sentence denotes Do not reduce immunosuppressive therapy in patients with mild COVID‐19
T101 7786-7933 Sentence denotes John Wiley & Sons, Ltd This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response.
T102 7934-8116 Sentence denotes It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.
T103 8118-8210 Sentence denotes How to Protect Medical Personnel and Patients With Liver Diseases From SARS‐CoV‐2 Infection?
T104 8211-8498 Sentence denotes To this end, all three associations recommend physical distancing by limiting face‐to‐face consultations to urgent situations, routine patient contact via telemedicine and phone visits, and use of local laboratories and pharmacies to reduce clinic and hospital visits and patient travel.
T105 8499-8650 Sentence denotes AASLD guidance is most stringent by discouraging clinic entry of anyone with fever or other COVID‐19 symptoms and SARS‐CoV‐2 testing of these patients.
T106 8651-8781 Sentence denotes All recommend COVID‐19 testing of liver transplant donors and recipients and patients with encephalopathy or acute decompensation.
T107 8782-8898 Sentence denotes Recent data showed that many SARS‐CoV‐2–infected patients are asymptomatic, yet capable of transmitting the disease.
T108 8899-9050 Sentence denotes 7 Ideally, all patients with a history of close contact with cases of possible or confirmed COVID‐19 or from high‐prevalence regions should be tested.
T109 9051-9133 Sentence denotes APASL recommends SARS‐CoV‐2 testing based on clinical and epidemiological factors.
T110 9134-9186 Sentence denotes EASL recommends following an institution’s practice.
T111 9187-9300 Sentence denotes AASLD and APASL describe the personal protective equipment (PPE) requirements for endoscopy and other procedures.
T112 9301-9373 Sentence denotes Like SARS‐CoV‐2 testing, the limiting factor is the availability of PPE.
T113 9374-9449 Sentence denotes Without adequate supply, many elective procedures will need to be canceled.
T114 9450-9552 Sentence denotes Modifications of the practice of liver transplantation (LT) are recommended by all three associations.
T115 9553-9742 Sentence denotes With the potential risks of SARS‐CoV‐2 transmission, aggravated by the limited supply of PPE and other resources, many governments have restricted elective medical procedures, including LT.
T116 9743-9854 Sentence denotes However, in the United States, LTs are considered “high‐acuity surgery” and can proceed as medically warranted.
T117 9855-10032 Sentence denotes 8 All associations recommend limiting LT to patients with high Model for End‐Stage Liver Disease scores, risk for decompensation, or hepatocellular carcinoma (HCC) progression.
T118 10034-10137 Sentence denotes Should LT be Performed in COVID‐19 Recipients, and Should One Use Organs Procured From COVID‐19 Donors?
T119 10138-10192 Sentence denotes AASLD recommends against LT in patients with COVID‐19.
T120 10193-10285 Sentence denotes LT can proceed 21 days after symptom resolution and negative diagnostic tests in recipients.
T121 10286-10392 Sentence denotes APASL suggests balancing risks of delaying LT against risks of transmission to health care workers (HCWs).
T122 10393-10439 Sentence denotes EASL does not specifically address this issue.
T123 10440-10636 Sentence denotes To minimize the risk to HCWs, APASL recommends LT be performed only in patients with COVID‐19 with at least two consecutive negative SARS‐CoV‐2 nucleic acid results and the presence of antibodies.
T124 10637-10735 Sentence denotes Finally, there is debate whether immunosuppression should be reduced during the COVID‐19 pandemic.
T125 10736-10847 Sentence denotes So far there are no data to suggest that posttransplant immunosuppression is a risk factor for severe COVID‐19.
T126 10848-10930 Sentence denotes In contrast, reducing immunosuppression may increase the risk for graft rejection.
T127 10931-11041 Sentence denotes All three associations recommend against reducing immunosuppressive therapy in LT patients with mild COVID‐19.
T128 11042-11191 Sentence denotes The dose of azathioprine, mycophenolate, and calcineurin inhibitor may be reduced in the setting of severe lymphopenia or worsening pulmonary status.
T129 11193-11275 Sentence denotes What Are the Roles of a Hepatologist in the Management of a Patient With COVID‐19?
T130 11276-11411 Sentence denotes Elevation of serum transaminase levels is commonly observed in patients with COVID‐19, and a hepatologist might therefore be consulted.
T131 11412-11588 Sentence denotes All of the guidance suggests that the underlying cause of liver injury may be related to SARS‐CoV‐2 infections, exacerbation of preexisting CLD, or drug‐induced hepatotoxicity.
T132 11589-11659 Sentence denotes AASLD and APASL provide an algorithm to clinical evaluations (Fig. 1).
T133 11660-11743 Sentence denotes A key question is whether patients with CLD have a higher risk for severe COVID‐19.
T134 11744-11929 Sentence denotes AASLD and APASL suggest nonalcoholic fatty liver disease (NAFLD) as an independent prognostic factor, and patients with CLD should be prioritized as candidates for COVID‐19 drug trials.
T135 11930-12058 Sentence denotes EASL and AASLD mention that patients with NAFLD are more likely than others to have other comorbidity risks for severe COVID‐19.
T136 12059-12235 Sentence denotes To date, there is no evidence that patients with stable CLD due to chronic hepatitis B (CHB) or chronic hepatitis C (CHC) have increased susceptibility to SARS‐CoV‐2 infection.
T137 12236-12385 Sentence denotes It is controversial whether there is an increased risk for flare‐up of CHB or CHC during COVID‐19 and whether prophylactic therapy should be started.
T138 12386-12479 Sentence denotes Both AASLD and APASL recommend continuing treatment for CHB or CHC in patients with COVID‐19.
T139 12480-12597 Sentence denotes APASL recommends prophylactic hepatitis B therapy for those planned for anti‐IL‐6 or other immunosuppressive therapy.
T140 12598-12661 Sentence denotes Initiating prophylactic hepatitis C therapy is not recommended.
T141 12662-12811 Sentence denotes If there is any suggestion of a flare‐up, therapy should be initiated in patients who are not already receiving hepatitis B or hepatitis C treatment.
T142 12812-12897 Sentence denotes Fig 1 Approach to the patient with COVID‐19 and elevated serum liver biochemistries.
T143 12898-12941 Sentence denotes Reproduced with permission from Hepatology.
T144 12942-13014 Sentence denotes 5 Copyright 2020, American Association for the Study of Liver Diseases.
T145 13015-13236 Sentence denotes On May 1, 2020, remdesivir, a nucleotide RNA polymerase inhibitor, was authorized by the US Food and Drug Administration under Emergency Use Authorization for treatment of those patients hospitalized with severe COVID‐19.
T146 13237-13373 Sentence denotes 9 APASL and AASLD recommend close monitoring of liver function in patients, especially those with CLD, who are treated with remdesivir.
T147 13374-13521 Sentence denotes Patients with decompensated CLD and those with alanine aminotransferase (ALT) >5 times upper limit of normal should not be treated with remdesivir.
T148 13523-13576 Sentence denotes How Should We Modify Management of Patients With HCC?
T149 13577-13702 Sentence denotes To avoid SARS‐CoV‐2 exposures, all associations recommend reducing patient visits and a delay in HCC ultrasound surveillance.
T150 13703-13986 Sentence denotes It is uncertain whether HCC treatment should be deferred or started as usual in patients with COVID‐19 with newly diagnosed HCC, and whether tyrosine kinase inhibitors (TKIs) or checkpoint inhibitors should be stopped in patients with COVID‐19 who are already receiving such therapy.
T151 13987-14256 Sentence denotes Delaying or withdrawing treatment increases the risk for HCC progression with detrimental outcomes, whereas surgical resection may increase risk for transmission to health care personnel, and checkpoint inhibitors might worsen COVID‐19 by exacerbating a cytokine storm.
T152 14257-14304 Sentence denotes AASLD recommends HCC treatments should proceed.
T153 14305-14447 Sentence denotes EASL recommends locoregional therapies should be postponed whenever possible and immune‐checkpoint inhibitor therapy be temporarily withdrawn.
T154 14448-14514 Sentence denotes TKI in nonsevere COVID‐19 should be taken on a case‐by‐case basis.
T155 14515-14757 Sentence denotes APASL recommends postponing elective transplant/resection surgery, whereas radiofrequency ablation, transcatheter arterial chemoembolization, TKI, or immunotherapy can be initiated with change of immunotherapy schedules to every 4 to 6 weeks.
T156 14759-14790 Sentence denotes How to Conduct Clinical Trials?
T157 14791-14922 Sentence denotes Both APASL and AASLD recommend using alternative physical distancing processes for study assessments to reduce SARS‐CoV‐2 exposure.
T158 14923-15181 Sentence denotes APASL specifically recommends seeking local regulators and institutional review board approval of the contingency measures during the COVID‐19 pandemic, obtaining trial participant’s consent, and documentation of all deviations from the contingency measures.
T159 15182-15307 Sentence denotes These recommendations align with US National Institutes of Health (NIH) revised guidance for NIH‐supported clinical research.
T160 15308-15310 Sentence denotes 10
T161 15312-15319 Sentence denotes Summary
T162 15320-15469 Sentence denotes APASL, AASLD, and EASL strongly recommend changes in patient workflow and clinical procedures to protect HCWs and patients from SARS‐CoV‐2 infection.
T163 15470-15747 Sentence denotes Similarly, the associations generally agree on approaches to evaluation and treatment of patients with COVID‐19 for liver disease, and management of patients with HCC and post–liver transplant patients with slight differences in the populations targeted for SARS‐CoV‐2 testing.
T164 15748-15858 Sentence denotes These recommendations will evolve with further clinical experience and data from randomized controlled trials.
T165 15859-15980 Sentence denotes For now, the liver associations provide the best available advice for the management of CLD during the COVID‐19 pandemic.

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 283-297 Phenotype denotes Liver Diseases http://purl.obolibrary.org/obo/HP_0001392
T2 421-438 Phenotype denotes chronic hepatitis http://purl.obolibrary.org/obo/HP_0200123
T3 445-462 Phenotype denotes chronic hepatitis http://purl.obolibrary.org/obo/HP_0200123
T4 477-490 Phenotype denotes liver disease http://purl.obolibrary.org/obo/HP_0001392
T5 582-591 Phenotype denotes hepatitis http://purl.obolibrary.org/obo/HP_0012115
T6 604-628 Phenotype denotes hepatocellular carcinoma http://purl.obolibrary.org/obo/HP_0001402
T7 633-642 Phenotype denotes hepatitis http://purl.obolibrary.org/obo/HP_0012115
T8 724-737 Phenotype denotes liver disease http://purl.obolibrary.org/obo/HP_0001392
T9 1111-1124 Phenotype denotes liver disease http://purl.obolibrary.org/obo/HP_0001392
T10 1597-1610 Phenotype denotes liver disease http://purl.obolibrary.org/obo/HP_0001392
T11 2122-2136 Phenotype denotes Liver Diseases http://purl.obolibrary.org/obo/HP_0001392
T12 2554-2567 Phenotype denotes Liver Disease http://purl.obolibrary.org/obo/HP_0001392
T13 3762-3775 Phenotype denotes liver disease http://purl.obolibrary.org/obo/HP_0001392
T14 3828-3837 Phenotype denotes cirrhosis http://purl.obolibrary.org/obo/HP_0001394
T15 3934-3948 Phenotype denotes encephalopathy http://purl.obolibrary.org/obo/HP_0001298
T16 4055-4068 Phenotype denotes liver disease http://purl.obolibrary.org/obo/HP_0001392
T17 4448-4457 Phenotype denotes hepatitis http://purl.obolibrary.org/obo/HP_0012115
T18 5513-5522 Phenotype denotes hepatitis http://purl.obolibrary.org/obo/HP_0012115
T19 5526-5535 Phenotype denotes hepatitis http://purl.obolibrary.org/obo/HP_0012115
T20 7651-7660 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T21 8169-8183 Phenotype denotes Liver Diseases http://purl.obolibrary.org/obo/HP_0001392
T22 8576-8581 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T23 8742-8756 Phenotype denotes encephalopathy http://purl.obolibrary.org/obo/HP_0001298
T24 9939-9952 Phenotype denotes Liver Disease http://purl.obolibrary.org/obo/HP_0001392
T25 9989-10013 Phenotype denotes hepatocellular carcinoma http://purl.obolibrary.org/obo/HP_0001402
T26 11149-11160 Phenotype denotes lymphopenia http://purl.obolibrary.org/obo/HP_0001888
T27 11276-11307 Phenotype denotes Elevation of serum transaminase http://purl.obolibrary.org/obo/HP_0002910
T28 11787-11800 Phenotype denotes liver disease http://purl.obolibrary.org/obo/HP_0001392
T29 12126-12143 Phenotype denotes chronic hepatitis http://purl.obolibrary.org/obo/HP_0200123
T30 12155-12172 Phenotype denotes chronic hepatitis http://purl.obolibrary.org/obo/HP_0200123
T31 12510-12519 Phenotype denotes hepatitis http://purl.obolibrary.org/obo/HP_0012115
T32 12622-12631 Phenotype denotes hepatitis http://purl.obolibrary.org/obo/HP_0012115
T33 12774-12783 Phenotype denotes hepatitis http://purl.obolibrary.org/obo/HP_0012115
T34 12789-12798 Phenotype denotes hepatitis http://purl.obolibrary.org/obo/HP_0012115
T35 12999-13013 Phenotype denotes Liver Diseases http://purl.obolibrary.org/obo/HP_0001392
T36 14241-14255 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T37 15586-15599 Phenotype denotes liver disease http://purl.obolibrary.org/obo/HP_0001392